NCT06066138 2026-04-16A Study of Therapeutic Drug Monitoring-Based Atezolizumab DosingNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting30 enrolled
NCT05333458 2026-04-13Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM TrialNational Cancer Institute (NCI)Phase 2 Recruiting27 enrolled